Global Pharmatech Inc
Global Pharmatech, Inc., through its subsidiaries, discovers, develops, manufactures, and markets proprietary therapeutical products based on Traditional Chinese Medicine (TCM). The company was founded in 2001 and is based in Mong Kok, Hong Kong.
Market Cap & Net Worth: Global Pharmatech Inc (GBLP)
Global Pharmatech Inc (PINK:GBLP) has a market capitalization of $100.48 Million ($100.48 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47193 globally and #14625 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Global Pharmatech Inc's stock price $0.24 by its total outstanding shares 415211785 (415.21 Million).
Global Pharmatech Inc Market Cap History: 2015 to 2025
Global Pharmatech Inc's market capitalization history from 2015 to 2025. Data shows change from $66.43 Million to $100.48 Million (-3.88% CAGR).
Global Pharmatech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Global Pharmatech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
227.04x
Global Pharmatech Inc's market cap is 227.04 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $83.04 Million | $58.59K | -$21.00K | 1417.47x | N/A |
| 2023 | $99.65 Million | $66.38K | -$138.50K | 1501.33x | N/A |
| 2024 | $70.59 Million | $310.89K | -$67.73K | 227.04x | N/A |
Competitor Companies of GBLP by Market Capitalization
Companies near Global Pharmatech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Global Pharmatech Inc by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Global Pharmatech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Global Pharmatech Inc's market cap moved from $66.43 Million to $ 100.48 Million, with a yearly change of -3.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $100.48 Million | +42.35% |
| 2024 | $70.59 Million | -29.17% |
| 2023 | $99.65 Million | +20.00% |
| 2022 | $83.04 Million | -23.08% |
| 2021 | $107.96 Million | +372.73% |
| 2020 | $22.84 Million | +497.83% |
| 2019 | $3.82 Million | -97.03% |
| 2018 | $128.72 Million | 0.00% |
| 2017 | $128.72 Million | -8.82% |
| 2016 | $141.17 Million | +112.50% |
| 2015 | $66.43 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Global Pharmatech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.48 Million USD |
| MoneyControl | $100.48 Million USD |
| MarketWatch | $100.48 Million USD |
| marketcap.company | $100.48 Million USD |
| Reuters | $100.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.